Skip to main content
. 2008 Jan 23;111(10):4902–4907. doi: 10.1182/blood-2007-10-116327

Table 2.

Predictors of venous thromboembolism in the derivation cohort by multivariate logistic regression analysis

Patient characteristic β Odds ratio* (95% CI)
Site of cancer
    Very high risk (stomach, pancreas) 1.46 4.3 (1.2-15.6)
    High risk (lung, lymphoma, gynecologic, genitourinary excluding prostate) 0.43 1.5 (0.9-2.7)
    Low risk (breast, colorectal, head and neck) 0.0 1.0 (reference)
Prechemotherapy platelet count 350 × 109/L or more 0.60 1.8 (1.1-3.2)
Hemoglobin level less than 100 g/L or use of red cell growth factors 0.89 2.4 (1.4-4.2)
Prechemotherapy leukocyte count more than 11 × 109/L 0.77 2.2 (1.2-4)
BMI 35 kg/m2 or more 0.90 2.5 (1.3-4.7)
*

Odds ratios are adjusted for stage.

HHS Vulnerability Disclosure